Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

A Novel Community-Based Strategy (Self-Sampling HPV Testing) to Improve Access to Cervical Cancer Screening in the Rio Grande Valley of Texas, the Prevencion en sus Manos Trial

Trial Status: active

This clinical trial evaluates the impact of self-sampling human papillomavirus virus (HPV) testing on cervical cancer screening in the Rio Grande Valley (RGV) of Texas. Cervical cancer may be preventable through vaccination against the virus that causes it, HPV, and through screening. Screening tests, including the Papanicolaou (Pap) smear and testing for HPV, are effective in identifying those at higher risk for developing cancer. However, many people do not have access to these tests because a pelvic exam with a healthcare provider is required. Self-sampling, collecting one's own sample, for HPV testing has been shown to work as well as sampling performed by a healthcare provider and may be an effective way to increase participation in screening for cervical cancer in the RGV of Texas.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.